PL1748779T3 - Transdermalna formulacja steroidowa - Google Patents
Transdermalna formulacja steroidowaInfo
- Publication number
- PL1748779T3 PL1748779T3 PL05738733T PL05738733T PL1748779T3 PL 1748779 T3 PL1748779 T3 PL 1748779T3 PL 05738733 T PL05738733 T PL 05738733T PL 05738733 T PL05738733 T PL 05738733T PL 1748779 T3 PL1748779 T3 PL 1748779T3
- Authority
- PL
- Poland
- Prior art keywords
- sup
- group
- weight
- steroid formulation
- acrylate
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0409498.3A GB0409498D0 (en) | 2004-04-28 | 2004-04-28 | Transdermal steroid formulation |
| PCT/GB2005/001596 WO2005105104A1 (en) | 2004-04-28 | 2005-04-28 | Transdermal steroid formulation |
| EP05738733A EP1748779B1 (en) | 2004-04-28 | 2005-04-28 | Transdermal steroid formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1748779T3 true PL1748779T3 (pl) | 2011-03-31 |
Family
ID=32408193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05738733T PL1748779T3 (pl) | 2004-04-28 | 2005-04-28 | Transdermalna formulacja steroidowa |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070231373A1 (pl) |
| EP (1) | EP1748779B1 (pl) |
| JP (1) | JP4849478B2 (pl) |
| KR (1) | KR101139023B1 (pl) |
| CN (1) | CN1997375B (pl) |
| AT (1) | ATE480241T1 (pl) |
| AU (1) | AU2005237285B2 (pl) |
| CA (1) | CA2563830C (pl) |
| CY (1) | CY1111318T1 (pl) |
| DE (1) | DE602005023436D1 (pl) |
| DK (1) | DK1748779T3 (pl) |
| ES (1) | ES2352202T3 (pl) |
| GB (1) | GB0409498D0 (pl) |
| HR (1) | HRP20100558T1 (pl) |
| IL (1) | IL178781A (pl) |
| NO (1) | NO337073B1 (pl) |
| NZ (1) | NZ550784A (pl) |
| PL (1) | PL1748779T3 (pl) |
| PT (1) | PT1748779E (pl) |
| RU (1) | RU2371183C2 (pl) |
| SI (1) | SI1748779T1 (pl) |
| TW (1) | TWI354557B (pl) |
| WO (1) | WO2005105104A1 (pl) |
| ZA (1) | ZA200608878B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0523550D0 (en) * | 2005-11-18 | 2005-12-28 | Hunter Fleming Ltd | Therapeutic uses of steroidal compounds |
| HRP20120687T1 (hr) * | 2006-11-30 | 2012-09-30 | Hunter-Fleming Limited | Moduliranje metabolizma prostaglandina/ciklooksigenaze |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3238389B2 (ja) * | 1988-10-27 | 2001-12-10 | シエーリング アクチエンゲゼルシヤフト | ゲストデン含有の経皮適用のための薬剤 |
| US4978532A (en) * | 1989-08-11 | 1990-12-18 | Pharmedic Co. | Dosage form for administration of dehydroepiandrosterone |
| US5565444A (en) * | 1993-05-18 | 1996-10-15 | Ltt Institute Co., Ltd. | Osteogenesis promoter and osteoporosis remedy |
| US5460820B1 (en) * | 1993-08-03 | 1999-08-03 | Theratech Inc | Method for providing testosterone and optionally estrogen replacement therapy to women |
| DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
| AU5671496A (en) * | 1995-05-15 | 1996-11-29 | Beth Israel Hospital | Use of dihydrotestosterone compounds for treating male sexual dysfunction |
| US5783208A (en) * | 1996-07-19 | 1998-07-21 | Theratech, Inc. | Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| KR100215027B1 (ko) * | 1997-01-27 | 1999-08-16 | 성재갑 | 스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형 |
| US20010023261A1 (en) * | 1997-01-27 | 2001-09-20 | Lg Chemical Limited. | Novel composition for the transdermal administration of drugs |
| DE19728517C2 (de) * | 1997-07-04 | 1999-11-11 | Sanol Arznei Schwarz Gmbh | TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung |
| US20020012694A1 (en) * | 1997-09-17 | 2002-01-31 | Alfred J. Moo-Young | Transdermal administration of ment |
| US5869090A (en) * | 1998-01-20 | 1999-02-09 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
| DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
| RU2234920C2 (ru) * | 1999-06-11 | 2004-08-27 | Уотсон Фармасьютикалс, Инк. | Введение непероральным путем андрогенных стероидов женщинам |
| GB2363984A (en) * | 2000-06-29 | 2002-01-16 | Hunter Fleming Ltd | Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids |
| GB2363983A (en) * | 2000-06-29 | 2002-01-16 | Hunter Fleming Ltd | Protection against neuronal damage using 7-hydroxyepiandrosterone |
| IL154693A0 (en) * | 2000-08-30 | 2003-09-17 | Unimed Pharmaceuticals Inc | Method of increasing testosterone and related steroid concentrations in women |
| FR2818148B1 (fr) * | 2000-12-15 | 2005-06-24 | Oreal | Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide |
| US6510801B2 (en) * | 2001-06-01 | 2003-01-28 | Hong Sin Tan | Pallet for shrinkwrapped packaging of block rubber |
| GB2378898A (en) * | 2001-08-14 | 2003-02-26 | Hunter Fleming Ltd | Prophylactic and therapeutic use of hydroxysteroids |
| EP1607104B1 (en) * | 2003-03-27 | 2015-12-09 | COSMED Pharmaceutical Co. Ltd. | Pressure-sensitive adhesive for percutaneous absorption, pressure-sensitive adhesive composition for percutaneous absorption, and medicinal preparation for percutaneous absorption |
-
2004
- 2004-04-28 GB GBGB0409498.3A patent/GB0409498D0/en not_active Ceased
- 2004-04-28 US US11/568,387 patent/US20070231373A1/en not_active Abandoned
-
2005
- 2005-04-27 TW TW094113457A patent/TWI354557B/zh not_active IP Right Cessation
- 2005-04-28 DE DE602005023436T patent/DE602005023436D1/de not_active Expired - Lifetime
- 2005-04-28 DK DK05738733.4T patent/DK1748779T3/da active
- 2005-04-28 RU RU2006141830/15A patent/RU2371183C2/ru not_active IP Right Cessation
- 2005-04-28 CN CN2005800175630A patent/CN1997375B/zh not_active Expired - Fee Related
- 2005-04-28 ES ES05738733T patent/ES2352202T3/es not_active Expired - Lifetime
- 2005-04-28 PL PL05738733T patent/PL1748779T3/pl unknown
- 2005-04-28 KR KR1020067024617A patent/KR101139023B1/ko not_active Expired - Fee Related
- 2005-04-28 NZ NZ550784A patent/NZ550784A/en not_active IP Right Cessation
- 2005-04-28 JP JP2007510103A patent/JP4849478B2/ja not_active Expired - Fee Related
- 2005-04-28 EP EP05738733A patent/EP1748779B1/en not_active Expired - Lifetime
- 2005-04-28 CA CA2563830A patent/CA2563830C/en not_active Expired - Fee Related
- 2005-04-28 HR HR20100558T patent/HRP20100558T1/hr unknown
- 2005-04-28 WO PCT/GB2005/001596 patent/WO2005105104A1/en not_active Ceased
- 2005-04-28 PT PT05738733T patent/PT1748779E/pt unknown
- 2005-04-28 AU AU2005237285A patent/AU2005237285B2/en not_active Ceased
- 2005-04-28 SI SI200531179T patent/SI1748779T1/sl unknown
- 2005-04-28 AT AT05738733T patent/ATE480241T1/de active
-
2006
- 2006-10-22 IL IL178781A patent/IL178781A/en not_active IP Right Cessation
- 2006-10-25 ZA ZA200608878A patent/ZA200608878B/xx unknown
- 2006-11-27 NO NO20065440A patent/NO337073B1/no not_active IP Right Cessation
-
2010
- 2010-12-01 CY CY20101101106T patent/CY1111318T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200504169A (en) | Pressure-sensitive adhesive for surface-protective film and surface-protective film | |
| TW200724635A (en) | Acrylic pressure-sensitive adhesive composition | |
| EP2135908A3 (en) | Pressure-sensitive adhesive composition and pressure-sensitive adhesive sheet to be attached to metal surface | |
| BRPI0818353A2 (pt) | Dispersões aquosas incluindo resina alquídica e polímero de adição tendo segmento(met)acrilato | |
| EP2135906A3 (en) | Pressure-sensitive adhesive composition and use thereof | |
| EP2135907A3 (en) | Pressure-sensitive adhesive composition, pressure-sensitive adhesive sheet, and method for producing the same | |
| WO2009005118A1 (ja) | アクリル系粘弾性組成物、及び感圧性接着テープ又はシート | |
| NZ524767A (en) | Composition for the transdermal delivery of fentanyl | |
| ATE508166T1 (de) | Copolymermischung | |
| EP2492330A3 (en) | Removable Water-Dispersible Acrylic Pressure-Sensitive Adhesive Composition and Pressure-Sensitive Adhesive Sheet | |
| TW200728399A (en) | Flame retardant polycarbonate resin composition having good impact, high heat resistance | |
| WO2009120412A3 (en) | Adhesive composition having non-tacky microspheres and sheets made therefrom | |
| ATE404250T1 (de) | Copolymere auf basis von tert.-butyl(meth)acrylat und deren verwendung in haarsprays | |
| EP2048213A4 (en) | FULL TASTING COMPOSITION AND LABEL FROM THIS | |
| MY160559A (en) | Adhesive and adhesive sheet | |
| WO2010049438A3 (en) | Improved methods of using phosphoantigens for the treatment of diseases | |
| EP2324860A3 (en) | Medical pressure-sensitive adhesive composition | |
| MXPA05007493A (es) | Nuevos copolimeros etilenicos, composiciones que los incluyen y procedimiento de tratamiento. | |
| CY1111318T1 (el) | Διαδερματικη φαρμακοτεχνικη μορφη στεροειδους | |
| MY209552A (en) | Hot-melt adhesive composition | |
| EP1702955B8 (en) | Pressure-sensitive adhesive composition and skin patch | |
| DE602005020996D1 (de) | Kaugummi und gummibasis enthaltend styrol-isopren-styrol-copolymere | |
| WO2006103568A3 (en) | NEW CLASS OF Ϝδ T CELLS ACTIVATORS AND USE THEREOF | |
| JP4361771B2 (ja) | 外用基材組成物 | |
| ATE355348T1 (de) | Medizinische unvernetzte druckempfindliche klebstoffzubereitung, damit versehene medizinische selbstklebefolie und, verfahren zur herstellung von einer medizinischen unvernetzten druckempfindlichen klebstoffzubereitung |